首页|18F-FDG PET/CT肿瘤内代谢异质性参数预测肺腺癌EGFR基因突变的价值

18F-FDG PET/CT肿瘤内代谢异质性参数预测肺腺癌EGFR基因突变的价值

Predictive value of intratumoral heterogeneity measured by 18F-FDG PET/CT for EGFR mutation of adenocarcinoma

扫码查看
目的 探讨18F-FDG PET/CT传统代谢参数、CT征象及肿瘤内代谢异质性参数预测肺腺癌表皮生长因子受体(EGFR)基因突变的价值.方法 回顾性纳入2016年1月至2020年6月间在济宁医学院附属医院经病理证实的147例肺腺癌患者[男73例、女74例,年龄(59.8±10.2)岁],分析EGFR基因突变组与野生组患者在临床资料(吸烟史、肿瘤位置及临床分期)、CT征象(最大径、有无磨玻璃成分、分叶征、毛刺征、空泡征、空气支气管征、胸膜凹陷征及支气管截断征)、18F-FDG PET/CT传统代谢参数[SUVmax、SUVmean、肿瘤代谢体积(MTV)及病灶糖酵解总量(TLG)]及肿瘤内代谢异质性参数[CV、异质性指数(HI)]间的差异.采用两独立样本t检验、Mann-Whitney U检验或x2检验分析数据;通过多因素logistic回归分析EGFR基因突变的预测因素;采用ROC曲线分析探讨不同参数对EGFR基因突变的预测效能.结果 147例患者中,EGFR基因突变型87例,EGFR野生型60例.2组患者在性别(男/女)、吸烟史(有/无)、原发灶位置(周围/中心)、胸膜凹陷征(有/无胸膜凹陷征)、SUVmax、SUVmean、TLG、CV及 HI 间的差异均有统计学意义(x2 值:4.72~23.89,z值:-2.31~5.74,均P<0.05).多因素 logistic 回归分析示,吸烟史[比值比(OR)=0.167,95%CI:0.076~0.366;P<0.001]、胸膜凹陷征(OR=1.404,95%CI:1.115~3.745;P=0.012)、SUVmax(OR=0.922,95%C7:0.855~0.995;P=0.003)、TLG(OR=0.991,95%CI:0.986~0.996;P=0.001)及 HI(OR=0.796,95%CI:0.700~0.859;P<0.001)是EGFR基因突变的预测因素.HI预测EGFR基因突变的AUC为0.779,灵敏度为76.67%(46/60)、特异性为79.31%(69/87);联合吸烟史、胸膜凹陷征、SUVmax、TLG及HI构建EGFR基因突变预测模型,AUC为0.908,灵敏度为88.33%(53/60)、特异性为68.97%(60/87).两者ROC AUC的差异有统计学意义(z=3.71,P<0.001).结论 HI预测肺腺癌EGFR基因突变价值较高,联合吸烟史、胸膜凹陷征、SUVmax、TLG时,预测能力更强.
Objective To investigate the value of traditional metabolic parameters,CT features and intratumoral heterogeneity parameters measured by 18 F-FDG PET/CT in predicting the mutation status of the epidermal growth factor receptor(EGFR)gene in patients with adenocarcinoma.Methods A total of 147 patients(73 males,74 females,age(59.8±10.2)years)with pathological confirmed adenocarcinoma be-tween January 2016 and June 2020 in the Affiliated Hospital of Jining Medical University were retrospectively included.The differences of clinical data(smoking history,tumor location and clinical stage),CT features(maximum diameter,ground-glass opacity content,lobulation,speculation,cavitation,air-bronchogram,pleural retraction and bronchial cut-off sign),18F-FDG PET/CT traditional metabolic parameters(SUVmax,SUVmean,metabolic tumor volume(MTV)and total lesion glycolysis(TLG))and intratumoral heterogenei-ty parameters(CV,heterogeneity index(HI))were analyzed between patients with EGFR mutation and pa-tients with EGFR wild-type.Independent-sample t test,Mann-Whitney U test and x2 test were used to ana-lyze the data.Multivariate logistic regression was used to analyze the predictors of EGFR mutation.ROC curve analysis was used to evaluate the predictive value of clinical and PET/CT information.Results Among 147 patients,87 were with EGFR mutation and 60 were with EGFR wild-type.There were significant differ-ences in gender(male/female),smoking history(with/without),location(peripheral lesion/central lesion),pleural retraction(with/without),SUVmax,SUVmean,TLG,CV and HI(x2 values:4.72-23.89,z values:from-2.31 to 5.74,all P<0.05).Multivariate logistic regression analysis showed that smoking history(odds ratio(OR)=0.167,95%CI:0.076-0.366;P<0.001),pleural retraction(OR=1.404,95%CI:1.115-3.745;P=0.012),SUVmax(OR=0.922,95%CI:0.855-0.995;P=0.003),TLG(OR=0.991,95%CI:0.986-0.996;P=0.001)and HI(OR=0.796,95%CI:0.700-0.859;P<0.001)were predictors of EGFR mutation.ROC curve analysis showed the AUC of HI was 0.779,with the sensitivity of 76.67%(46/60)and the specificity of 79.31%(69/87).The predictive model was constructed by combining smoking history,pleural retraction,TLG,SUVmax and HI,and the AUC was 0.908,with the sensitivity of 88.33%(53/60)and the specificity of 68.97%(60/87).The difference of AUCs between HI and the predictive model was statistically significant(z=3.71,P<0.001).Conclusion HI can predict EGFR mutations better,and the predictive value for EGFR mutations can be enhanced when combining HI with smoking history,pleural re-traction,TLG and SUVmax.

Lung neoplasmsAdenocarcinomaMutationReceptor,epidermal growth factorPositron-emission tomographyTomography,X-ray computedFluorodeoxyglucose F18

程楠、张谷青、高明、王寻、孔钰

展开 >

济宁医学院附属医院医学影像科,济宁 272000

肺肿瘤 腺癌 突变 受体,表皮生长因子 正电子发射断层显像术 体层摄影术,X线计算机 氟脱氧葡萄糖F18

2024

中华核医学与分子影像杂志
中华医学会

中华核医学与分子影像杂志

CSTPCD北大核心
影响因子:1.107
ISSN:2095-2848
年,卷(期):2024.44(1)
  • 1
  • 2